Vaccines highly effective against hospitalisation from Delta variant

New analysis by PHE shows for the first time that 2 doses of COVID-19 vaccines are highly effective against hospitalisation from the Delta (B.1.617.2) variant.

The analysis suggests:

• the Pfizer-BioNTech vaccine is 96% effective against hospitalisation after 2 doses
• the Oxford-AstraZeneca vaccine is 92% effective against hospitalisation after 2 doses

Public Health England (PHE) has previously published analysis showing that one dose is 17% less effective at preventing symptomatic illness from the Delta variant, compared to Alpha, but there is only a small difference after 2 doses.
https://www.gov.uk/government/news/vaccines-highly-effective-against-hospitalisation-from-delta-variant